Search results for "MESENCHYMAL STEM CELLS"

showing 10 items of 213 documents

Human exfoliated deciduous teeth and oral mucosa: promising applications in tissue regeneration

2018

In the last three decades, the constantly increasing need for therapies, efficiently preventing and/or treating human diseases, has raised the interest in Regenerative Medicine (RM). RM is based on employing mesenchymal stem cells (MSCs), that showed to have great proliferation, self-renewal and multilineage differentiation potential, in vitro as well as in vivo. The opportunity of an accessible, painless and low-cost reservoir of MSCs constitutes the first important step of a successful regenerative therapy to include in the current clinical practice. Oral cavity has recently demonstrated to contain different MSCs niches: dental pulp from permanent and deciduous teeth, periodontal ligament…

Oral cavity Deciduous teeth Oral mucosa Mesenchymal stem cells Tissue regeneration Pediatricsmedicine.anatomical_structurebusiness.industryDeciduous teethDentistryMedicineOral mucosabusiness
researchProduct

The expression of PTHrP isoforms in differentiating human fat-derived mesenchymal stem cells

2012

PTHrP breast cancer mesenchymal stem cells gene expressionSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

PTHrP isoform expression in adipo- and osteo-differentiating human mesenchymal stem cells

2011

PTHrPSettore BIO/06 - Anatomia Comparata E Citologiamesenchymal stem cells gene expression promoter methylation
researchProduct

Reconstruction of Endometrium from Human Endometrial Side Population Cell Lines

2011

Endometrial regeneration is mediated, at least in part, by the existence of a specialized somatic stem cell (SSC) population recently identified by several groups using the side population (SP) technique. We previously demonstrated that endometrial SP displays genotypic, phenotypic and the functional capability to develop human endometrium after subcutaneous injection in NOD-SCID mice. We have now established seven human endometrial SP (hESP) cell lines (ICE 1-7): four from the epithelial and three from the stromal fraction, respectively. SP cell lines were generated under hypoxic conditions based on their cloning efficiency ability, cultured for 12-15 passages (20 weeks) and cryopreserved.…

PathologyAnatomy and PhysiologyCellular differentiationlcsh:MedicineVimentinCell SeparationMice SCIDEndometriumEndometriumMice0302 clinical medicineMice Inbred NODReproductive PhysiologyMolecular Cell Biologylcsh:ScienceSide-Population CellsMedicine(all)0303 health scienceseducation.field_of_study030219 obstetrics & reproductive medicineMultidisciplinaryAgricultural and Biological Sciences(all)biologyStem CellsObstetrics and GynecologyCell DifferentiationAdult Stem Cellsmedicine.anatomical_structurePhenotypeSomatic CellsMedicineFemaleCellular Types/dk/atira/pure/subjectarea/asjc/2700Receptors ProgesteroneAdult stem cellResearch Articlemedicine.medical_specialtyStromal cellPopulationCell Line/dk/atira/pure/subjectarea/asjc/130003 medical and health sciencesSide population/dk/atira/pure/subjectarea/asjc/1100medicineAnimalsHumansRegenerationeducationBiology030304 developmental biologyBiochemistry Genetics and Molecular Biology(all)lcsh:RMesenchymal stem cellEstrogen Receptor alphaReproductive SystemEpithelial CellsMesenchymal Stem CellsMolecular biologyKaryotypingbiology.proteinlcsh:QStromal CellsStem Cell LinesBiomarkersCytometry
researchProduct

Isolation and Characterization of CD276+/HLA-E+ Human Subendocardial Mesenchymal Stem Cells from Chronic Heart Failure Patients: Analysis of Differen…

2012

Mesenchymal stem cells (MSCs) are virtually present in all postnatal organs as well as in perinatal tissues. MSCs can be differentiated toward several mature cytotypes and interestingly hold potentially relevant immunomodulatory features. Myocardial infarction results in severe tissue damage, cardiomyocyte loss, and eventually heart failure. Cellular cardiomyoplasty represents a promising approach for myocardial repair. Clinical trials using MSCs are underway for a number of heart diseases, even if their outcomes are hampered by low long-term improvements and the possible presence of complications related to cellular therapy administration. Therefore, elucidating the presence and role of MS…

Pathologymedicine.medical_specialtyB7 AntigensHeart VentriclesGene ExpressionCell SeparationBiologyCell therapyHLA-EAntigens CDOsteogenesisCellular cardiomyoplastymedicineHumansImmunologic FactorsMyocardial infarctionCells CulturedHeart FailureAdipogenesisMesenchymal stem cells human heart stromal progenitors post-infarct chronic heart failure cardiomyocyte markers immune modulation inflammation cardiac remodelling regenerative medicineSettore BIO/16 - Anatomia UmanaHistocompatibility Antigens Class IMesenchymal stem cellMesenchymal Stem CellsCell BiologyHematologyAnatomymedicine.diseaseClinical trialmedicine.anatomical_structureVentricleHeart failureChondrogenesisBiomarkersDevelopmental BiologyStem Cells and Development
researchProduct

Wharton's Jelly Stem Cells: A Novel Cell Source for Oral Mucosa and Skin Epithelia Regeneration

2013

Abstract Perinatal stem cells such as human umbilical cord Wharton's jelly stem cells (HWJSCs) are excellent candidates for tissue engineering because of their proliferation and differentiation capabilities. However, their differentiation potential into epithelial cells at in vitro and in vivo levels has not yet been reported. In this work we have studied the capability of HWJSCs to differentiate in vitro and in vivo to oral mucosa and skin epithelial cells using a bioactive three-dimensional model that mimics the native epithelial-mesenchymal interaction. To achieve this, primary cell cultures of HWJSCs, oral mucosa, and skin fibroblasts were obtained in order to generate a three-dimension…

Pathologymedicine.medical_specialtyFluorescent Antibody TechniqueMice NudeFilaggrin ProteinsBiologyModels BiologicalEpitheliumMiceIntermediate Filament ProteinsTissue engineeringTissue Engineering and Regenerative MedicineWharton's jellymedicineAnimalsHumansRegenerationWharton JellyProtein PrecursorsOral mucosaInvolucrinSkinRegeneration (biology)Mouth MucosaCell DifferentiationEpithelial CellsMesenchymal Stem CellsCell BiologyGeneral MedicineFlow CytometryCell biologymedicine.anatomical_structureCell cultureKeratinsLeukocyte Common AntigensThy-1 Antigensgamma CateninStem cellDevelopmental BiologyAdult stem cellStem Cells Translational Medicine
researchProduct

Isolation, cultivation and characterization of human somatic stem cells from adult skin, adipose tissue and bone marrow

2008

Isolation, cultivation and characterization of human somatic stem cells from adult skin, adipose tissue and bone marrow

Pathologymedicine.medical_specialtyInduced stem cellsintegumentary systemClinical uses of mesenchymal stem cellsAdipose tissueCell BiologyBiologyStem cell markermedicine.anatomical_structureImmunologymedicineBone marrowStem cellMolecular BiologyStem cell transplantation for articular cartilage repairAdult stem cellCell Research
researchProduct

Contribution of different bone marrow-derived cell types in endometrial regeneration using an irradiated murine model.

2015

Objective To study the involvement of seven types of bone marrow-derived cells (BMDCs) in the endometrial regeneration in mice after total body irradiation. Design Prospective experimental animal study. Setting University research laboratories. Animal(s) β-Actin-green fluorescent protein (GFP) transgenic C57BL/6-Tg (CAG-EGFP) and C57BL/6J female mice. Intervention(s) The BMDCs were isolated from CAG-EGFP mice: unfractionated bone marrow cells, hematopoietic progenitor cells, endothelial progenitor cells (EPCs), and mesenchymal stem cells (MSCs). In addition three murine GFP + cell lines were used: mouse Oct4 negative BMDC multipotent adult progenitor cells (mOct4 − BM-MAPCs), BMDC hypoblast…

Pathologymedicine.medical_specialtyStromal cellBone Marrow CellsBiologyEndometriumMicemedicineAnimalsRegenerationProgenitor cellCells CulturedMesenchymal stem cellObstetrics and GynecologyCell DifferentiationMesenchymal Stem CellsTotal body irradiationMolecular biologyBone Marrow-Derived CellTransplantationMice Inbred C57BLmedicine.anatomical_structureReproductive MedicineFemaleBone marrowStem cellWhole-Body IrradiationFertility and sterility
researchProduct

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.

2010

Background Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV− Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) i…

Pathologymedicine.medical_specialtyStromal cellTransplantation HeterologousMice Nudelcsh:Medicinemesenchimal stem cellsMice SCIDMiceimmune system diseaseshemic and lymphatic diseasesmesenchymal stem cells non-Hodgkin's lymphoma.AnimalsHumansMedicinehuman lymphoma xenograft; mesenchimal stem cellsOncology/Hematological Malignancieslcsh:ScienceSCID MiceMultidisciplinaryHematology/Bone Marrow and Stem Cell Transplantationbusiness.industryLymphoma Non-HodgkinLymphoblastlcsh:RMesenchymal stem cellNon-Hodgkin's LymphomaMesenchymal Stem CellsHematopoietic Stem Cellsmedicine.diseaseCoculture TechniquesLymphomaNon-Hodgkin's lymphomaEndothelial stem cellTransplantationApoptosislcsh:QHematology/Lymphomas and Chronic Lymphoblastic LeukemiabusinessMesenchymal Stem Cells; SCID Mice; Non-Hodgkin's LymphomaResearch Articlehuman lymphoma xenograft
researchProduct

Cardiac tissue engineering: a reflection after a decade of hurry

2014

The heart is a perfect machine whose mass is mainly composed of cardiomyocytes, but also fibroblasts, endothelial, smooth muscle, nervous, and immune cells are represented. One thousand million cardiomyocytes are estimated to be lost after myocardial infarction, their loss being responsible for the impairment in heart contractile function (Laflamme and Murry, 2005). The potential success of cardiac cell therapy relies almost completely on the ability of the implanted cells to differentiate toward mature cardiomyocytes. These cells must be able to reinforce the pumping activity of the injured heart in the absence of life-threatening arrhythmias due to electrophysiological incompatibility. Th…

Pathologymedicine.medical_specialtyheart regenerationPhysiologycardiac progenitor cellsClinical uses of mesenchymal stem cellsproto-tissueslcsh:PhysiologyTissue engineeringPhysiology (medical)MedicineInduced pluripotent stem cellStem cell transplantation for articular cartilage repairlcsh:QP1-981business.industryRegeneration (biology)Mesenchymal stem cellOpinion Articletissue engineeringscaffoldsStem cellbusinessNeurosciencecardiac progenitor cells proto-tissues heart regeneration tissue engineering scaffolds biomaterialsbiomaterialsAdult stem cell
researchProduct